BIOMAT Database Logo BIOMAT Database Logo

Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes. 2009

Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Tohon, Ehime, Japan.

OBJECTIVE We examined the possibility that activation of the human brain renin-angiotensin system is involved in enhancement of ischemic brain damage using chimeric transgenic mice with human renin (hRN) and human angiotensinogen (hANG) genes. METHODS Chimeric (hRN/hANG-Tg) mice were generated by mating of hRN and hANG transgenic mice. Permanent occlusion of the middle cerebral artery (MCA) by an intraluminal filament technique induced focal ischemic brain lesions. RESULTS hRN/hANG-Tg mice showed higher angiotensin II levels in the plasma and brain. The ischemic brain area at 24 hours after MCA occlusion was significantly enlarged in hRN/hANG-Tg mice with an enhanced neurological deficit compared to that in wild-type, hRN-Tg and hANG-Tg mice. The reduction of cerebral blood flow in the periphery region of the MCA territory after MCA occlusion was markedly exaggerated in hRN/hANG-Tg mice. Superoxide anion production in the brain and arteries was also increased significantly in hRN/hANG-Tg mice even before MCA occlusion and was further enhanced after MCA occlusion. Treatment with an AT(1) receptor blocker, valsartan (3.0 mg/kg per day), for 2 weeks significantly reduced the ischemic brain area and improved the neurological deficit after MCA occlusion in hRN/hANG-Tg mice, similar to those in wild-type, hRN-Tg, and hANG-Tg mice, with restoration of cerebral blood flow in the peripheral region and decreases in superoxide anion production and blood pressure. CONCLUSIONS These results indicate that activation of the human renin-angiotensin system exaggerates ischemic brain damage mainly through stimulation of the AT(1) receptor and marked reduction of cerebral blood flow and enhanced oxidative stress.

UI MeSH Term Description Entries
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068756 Valsartan A tetrazole derivative and ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to treat HYPERTENSION. CGP 48933,Diovan,Kalpress,Miten,N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine,Nisis,Provas,Tareg,Vals,48933, CGP
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes.
June 1993, The Journal of biological chemistry,
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Development of polyuria in Tsukuba hypertensive mice carrying human renin and angiotensinogen genes.
December 1995, Clinical and experimental pharmacology & physiology. Supplement,
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice.
November 2009, American journal of physiology. Regulatory, integrative and comparative physiology,
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes.
March 1998, Hypertension research : official journal of the Japanese Society of Hypertension,
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Dependence of angiotensin production in transgenic mice carrying either the human renin or human angiotensinogen genes on species-specific kinetics of the renin-angiotensin system.
February 1993, Arzneimittel-Forschung,
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes.
February 1996, The Journal of clinical investigation,
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen.
January 2003, Hypertension (Dallas, Tex. : 1979),
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes.
August 1992, Proceedings of the National Academy of Sciences of the United States of America,
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Appropriate regulation of renin and blood pressure in 45-kb human renin/human angiotensinogen transgenic mice.
January 1999, Hypertension (Dallas, Tex. : 1979),
Shinji Inaba, and Masaru Iwai, and Yumiko Tomono, and Izumi Senba, and Megumi Furuno, and Harumi Kanno, and Hideki Okayama, and Masaki Mogi, and Jitsuo Higaki, and Masatsugu Horiuchi
Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen.
March 2000, Stroke,
Copied contents to your clipboard!